Single dose regorafenib-induced hypertensive crisis
Gastrointestinal stromal tumors (GISTs) are uncommon tumors of the gastrointestinal (GI) tract. Regorafenib is a new multikinase inhibitor and is approved for the treatment of GISTs in patients who develop resistance to imatinib and sunitinib. The most common drug-related adverse events with regoraf...
Gespeichert in:
| Veröffentlicht in: | Experimental Oncology |
|---|---|
| Datum: | 2014 |
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | Englisch |
| Veröffentlicht: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2014
|
| Schlagworte: | |
| Online Zugang: | https://nasplib.isofts.kiev.ua/handle/123456789/145356 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Zitieren: | Single dose regorafenib-induced hypertensive crisis / B. Yilmaz, Y. Kemal, F. Teker, E. Kut, G. Demirag, I. Yucel // Experimental Oncology. — 2014. — Т. 36, № 2. — С. 134-135. — Бібліогр.: 15 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of Ukraine| _version_ | 1862651735931092992 |
|---|---|
| author | Yilmaz, B. Kemal, Y. Teker, F. Kut, E. Demirag, G. Yucel, I. |
| author_facet | Yilmaz, B. Kemal, Y. Teker, F. Kut, E. Demirag, G. Yucel, I. |
| citation_txt | Single dose regorafenib-induced hypertensive crisis / B. Yilmaz, Y. Kemal, F. Teker, E. Kut, G. Demirag, I. Yucel // Experimental Oncology. — 2014. — Т. 36, № 2. — С. 134-135. — Бібліогр.: 15 назв. — англ. |
| collection | DSpace DC |
| container_title | Experimental Oncology |
| description | Gastrointestinal stromal tumors (GISTs) are uncommon tumors of the gastrointestinal (GI) tract. Regorafenib is a new multikinase inhibitor and is approved for the treatment of GISTs in patients who develop resistance to imatinib and sunitinib. The most common drug-related adverse events with regorafenib are hypertension, hand-foot skin reactions, and diarrhea. Grade IV hypertensive side effect has never been reported after a single dose. In this report, we present a case of Grade IV hypertensive side effect (hypertensive crisis and seizure) after a single dose of regorafenib. A 54-year-old male normotensive GIST patient was admitted to the emergency department with seizure and encephalopathy after the first dosage of regorafenib. His blood pressure was 240/140 mmHg upon admission. After intensive treatment with nitrate and nitroprusside, his blood pressure returned to normal levels in five days. Regorafenib was discontinued, and he did not experience hypertension again. This paper reports the first case of Grade IV hypertension after the first dosage of regorafenib. We can suggest that hypertension is an idiosyncratic side effect unrelated to the dosage. Key Words: hypertension, regorafenib, gastrointestinal stromal tumor.
|
| first_indexed | 2025-12-01T19:55:24Z |
| format | Article |
| fulltext | |
| id | nasplib_isofts_kiev_ua-123456789-145356 |
| institution | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| issn | 1812-9269 |
| language | English |
| last_indexed | 2025-12-01T19:55:24Z |
| publishDate | 2014 |
| publisher | Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
| record_format | dspace |
| spelling | Yilmaz, B. Kemal, Y. Teker, F. Kut, E. Demirag, G. Yucel, I. 2019-01-20T19:23:45Z 2019-01-20T19:23:45Z 2014 Single dose regorafenib-induced hypertensive crisis / B. Yilmaz, Y. Kemal, F. Teker, E. Kut, G. Demirag, I. Yucel // Experimental Oncology. — 2014. — Т. 36, № 2. — С. 134-135. — Бібліогр.: 15 назв. — англ. 1812-9269 https://nasplib.isofts.kiev.ua/handle/123456789/145356 Gastrointestinal stromal tumors (GISTs) are uncommon tumors of the gastrointestinal (GI) tract. Regorafenib is a new multikinase inhibitor and is approved for the treatment of GISTs in patients who develop resistance to imatinib and sunitinib. The most common drug-related adverse events with regorafenib are hypertension, hand-foot skin reactions, and diarrhea. Grade IV hypertensive side effect has never been reported after a single dose. In this report, we present a case of Grade IV hypertensive side effect (hypertensive crisis and seizure) after a single dose of regorafenib. A 54-year-old male normotensive GIST patient was admitted to the emergency department with seizure and encephalopathy after the first dosage of regorafenib. His blood pressure was 240/140 mmHg upon admission. After intensive treatment with nitrate and nitroprusside, his blood pressure returned to normal levels in five days. Regorafenib was discontinued, and he did not experience hypertension again. This paper reports the first case of Grade IV hypertension after the first dosage of regorafenib. We can suggest that hypertension is an idiosyncratic side effect unrelated to the dosage. Key Words: hypertension, regorafenib, gastrointestinal stromal tumor. en Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України Experimental Oncology Case report Single dose regorafenib-induced hypertensive crisis Article published earlier |
| spellingShingle | Single dose regorafenib-induced hypertensive crisis Yilmaz, B. Kemal, Y. Teker, F. Kut, E. Demirag, G. Yucel, I. Case report |
| title | Single dose regorafenib-induced hypertensive crisis |
| title_full | Single dose regorafenib-induced hypertensive crisis |
| title_fullStr | Single dose regorafenib-induced hypertensive crisis |
| title_full_unstemmed | Single dose regorafenib-induced hypertensive crisis |
| title_short | Single dose regorafenib-induced hypertensive crisis |
| title_sort | single dose regorafenib-induced hypertensive crisis |
| topic | Case report |
| topic_facet | Case report |
| url | https://nasplib.isofts.kiev.ua/handle/123456789/145356 |
| work_keys_str_mv | AT yilmazb singledoseregorafenibinducedhypertensivecrisis AT kemaly singledoseregorafenibinducedhypertensivecrisis AT tekerf singledoseregorafenibinducedhypertensivecrisis AT kute singledoseregorafenibinducedhypertensivecrisis AT demiragg singledoseregorafenibinducedhypertensivecrisis AT yuceli singledoseregorafenibinducedhypertensivecrisis |